Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	16.52	25.8	28.68	15.36	90.54	105.14
Short-Term Investments	24.12	33.48	51.73	69.49	67.04	103.35
Cash & Short-Term Investments	40.63	59.28	80.41	84.85	157.58	208.49
Cash Growth	-39.67%	-26.27%	-5.24%	-46.15%	-24.42%	-46.67%
Accounts Receivable	79.93	78.88	60.14	52.05	35.5	41.85
Inventory	72.97	53.16	42.11	54.57	48.38	41.91
Other Current Assets	17.39	17.69	6.12	13.96	12.96	21.95
Total Current Assets	210.92	209.01	188.77	205.44	254.42	314.2
Net Property, Plant & Equipment	15.08	17.65	25.6	29.81	33.56	39.01
Other Long-Term Assets	6.08	6.48	8.13	15.71	17.72	0.35
Total Assets	232.09	233.15	222.51	250.95	305.71	353.56
Accounts Payable	12.04	11.71	3.24	3.23	3.8	0.53
Accrued Expenses	23.61	34.96	31.52	37.88	38.98	63.56
Short-Term Debt	175.2	-	-	-	-	7.05
Current Portion of Leases	1.54	3.04	3.08	2.69	2.42	3
Other Current Liabilities	46.22	41.76	41.86	38.55	25.86	28.37
Total Current Liabilities	258.6	91.46	79.69	82.36	71.06	102.5
Long-Term Debt	-	174.73	173.75	149.28	149.08	-
Long-Term Leases	-	-	2.8	5.5	8	14.56
Other Long-Term Liabilities	0.75	0.62	0.24	0.24	-	-
Total Long-Term Liabilities	0.75	175.34	176.79	155.02	157.08	14.56
Total Liabilities	259.35	266.8	256.48	237.38	228.14	117.06
Common Stock	1.53	1.52	1.5	1.19	1.02	0.91
Additional Paid-in Capital	1,891	1,884	1,871	1,808	1,690	1,628
Accumulated Other Comprehensive Income	-0	0.01	0.01	-0.02	-0.01	0.26
Retained Earnings	-1,919	-1,920	-1,906	-1,795	-1,613	-1,393
Shareholders' Equity	-27.26	-33.65	-33.97	13.57	77.57	236.49
Total Liabilities & Equity	232.09	233.15	222.51	250.95	305.71	353.56
Total Debt	176.74	177.76	179.63	157.48	159.5	24.61
Net Cash (Debt)	-136.11	-118.48	-99.22	-72.63	-1.92	183.88
Net Cash Growth	-	-	-	-	-	-50.46%
Net Cash Per Share	-0.83	-0.78	-0.72	-0.67	-0.02	2.03
Book Value	-27.26	-33.65	-33.97	13.57	77.57	236.49
Book Value Per Share	-0.17	-0.22	-0.25	0.12	0.79	2.61
Tangible Book Value	-27.26	-33.65	-33.97	13.57	77.57	236.49
Tangible Book Value Per Share	-0.17	-0.22	-0.25	0.12	0.79	2.61

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q